We are live on
!
Find out more
DII
Domini Impact Investments Portfolio holdings
AUM
$7.59M
1-Year Est. Return
47.68%
This Fund
S&P 500
This Quarter
Est. Return
-4.6%
1 Year Est. Return
+47.68%
3 Year Est. Return
+231.06%
5 Year Est. Return
+291.89%
10 Year Est. Return
–
AUM
$4.03M
AUM Growth
-$1.11M
(-22%)
Cap. Flow
-$874K
Cap. Flow
% of AUM
-21.71%
Top 10 Holdings %
Top 10 Hldgs %
96.25%
Holding
15
New
1
Increased
1
Reduced
9
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$338K |
| 2 |
Autodesk
ADSK
|
+$25.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sarepta Therapeutics
SRPT
|
+$265K |
| 2 |
HOLX
Hologic
HOLX
|
+$214K |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$209K |
| 4 |
Celldex Therapeutics
CLDX
|
+$180K |
| 5 |
Gilead Sciences
GILD
|
+$66.2K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.87% |
| 2 | Technology | 31.68% |
| 3 | Industrials | 13.53% |
| 4 | Consumer Staples | 12.14% |
| 5 | Consumer Discretionary | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Gilead Sciences
GILD
$162B
| $574K | 14.25% |
6,245
-734
| -11% | -$66.2K |
|
2
OraSure Technologies
OSUR
$275M
| $550K | 13.65% |
76,061
-8,941
| -11% | -$56.9K |
|
3
First Solar
FSLR
$22.1B
| $468K | 11.62% |
6,840
-802
| -10% | -$53.8K |
|
4
Universal Display
OLED
$3.82B
| $426K | 10.58% |
7,874
-926
| -11% | -$45.3K |
|
5
Acuity Brands
AYI
$10.1B
| $394K | 9.78% |
1,806
-210
| -10% | -$43.3K |
|
|
6
Tesla
TSLA
$1.22T
| $394K | 9.78% |
+25,695
| New | +$338K |
|
|
7
Autodesk
ADSK
$47.6B
| $382K | 9.48% |
6,554
+494
| +8% | +$25.8K |
|
|
STKL
8
DELISTED
SunOpta
STKL
| $258K | 6.41% |
57,866
-6,807
| -11% | -$37.2K |
|
9
Vitamin Cottage Natural Grocers
NGVC
$731M
| $231K | 5.73% |
10,860
-1,279
| -11% | -$25.7K |
|
|
NTUS
10
DELISTED
Natus Medical Inc
NTUS
| $200K | 4.97% |
5,203
-611
| -11% | -$22.8K |
|
11
Ameresco
AMRC
$1.12B
| $151K | 3.75% |
31,719
-3,735
| -11% | -$19K |
|
|
12
Celldex Therapeutics
CLDX
$2.8B
| – | – |
-763
| Closed | -$180K |
|
|
HOLX
13
DELISTED
Hologic
HOLX
| – | – |
-5,520
| Closed | -$214K |
|
|
14
Sarepta Therapeutics
SRPT
$1.69B
| – | – |
-6,872
| Closed | -$265K |
|
|
SGEN
15
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
-4,657
| Closed | -$209K |
|
Similar funds
SWM
PIM
MCM
SLI
CWSR
ACM
ECAU
SL
Domini Impact Investments's Q1 2016 Portfolio in Review
As of Q1 2016, Domini Impact Investments held 15 positions worth $4.03M, down 22% from $5.13M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Domini Impact Investments withdrew a net $874K in Q1 2016, closing 4 positions and reducing 9 holdings. Its most notable exit was Sarepta Therapeutics, an estimated $265K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 47% a quarter earlier, followed by Technology and Industrials.
Against the trend, Domini Impact Investments opened a new position in Tesla worth $394K.
- Domini Impact Investments's largest Q1 2016 buy was Tesla: 25,695 shares worth $394K.
- Domini Impact Investments added most to Autodesk in Q1 2016, an estimated $25.8K increase.
- Domini Impact Investments's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $66.2K.
- Domini Impact Investments fully exited Sarepta Therapeutics in Q1 2016, selling an estimated $265K.
- Domini Impact Investments's ten largest holdings make up 96% of its $4.03M portfolio in Q1 2016.
- Domini Impact Investments opened 1 new position and closed 4 in Q1 2016.
- Domini Impact Investments's portfolio value fell 22% quarter-over-quarter to $4.03M.
Based on Domini Impact Investments's 13F filing for Q1 2016, filed 12 May 2016.